Comprehensive Molecular Characterization of Muscle-Invasive Bladder Cancer

被引：1197

作者：

Robertson, A. Gordon ^{[1
]}

Kim, Jaegil ^{[2
]}

Al-Ahmadie, Hikmat ^{[3
]}

Bellmunt, Joaquim ^{[4
,5
]}

Guo, Guangwu ^{[5
,6
]}

Cherniack, Andrew D. ^{[2
]}

Hinoue, Toshinori ^{[7
]}

Laird, Peter W. ^{[7
]}

Hoadley, Katherine A. ^{[8
]}

Akbani, Rehan ^{[9
]}

Castro, Mauro A. A. ^{[10
]}

Gibb, Ewan A. ^{[1
]}

Kanchi, Rupa S. ^{[9
]}

Gordenin, Dmitry A. ^{[11
]}

Shukla, Sachet A. ^{[5
,6
]}

Sanchez-Vega, Francisco ^{[12
]}

Hansel, Donna E. ^{[13
]}

Czerniak, Bogdan A. ^{[14
]}

Reuter, Victor E. ^{[3
]}

Su, Xiaoping ^{[9
]}

Carvalho, Benilton de Sa ^{[15
]}

Chagas, Vinicius S. ^{[10
]}

Mungall, Karen L. ^{[1
]}

Sadeghi, Sara ^{[1
]}

Pedamallu, Chandra Sekhar ^{[2
]}

Lu, Yiling ^{[16
]}

Klimczak, Leszek J. ^{[17
]}

Zhang, Jiexin ^{[9
]}

Choo, Caleb ^{[1
]}

Ojesina, Akinyemi I. ^{[18
]}

Bullman, Susan ^{[2
]}

Leraas, Kristen M. ^{[19
]}

Lichtenberg, Tara M. ^{[19
]}

Wu, Catherine J. ^{[20
]}

Schultz, Nicholaus ^{[12
]}

Getz, Gad ^{[2
]}

Meyerson, Matthew ^{[5
,21
]}

Mills, Gordon B. ^{[16
]}

McConkey, David J. ^{[22
]}

Weinstein, John N. ^{[9
,16
]}

Kwiatkowski, David J. ^{[23
]}

Lerner, Seth P. ^{[24
]}

机构：

[1] BC Canc Agcy, Canadas Michael Smith Genome Sci Ctr, Vancouver, BC V5Z 4S6, Canada

[2] Broad Inst MIT & Harvard, Canc Program, Cambridge, MA 02142 USA

[3] Mem Sloan Kettering Canc Ctr, Dept Pathol, New York, NY 10065 USA

[4] Dana Farber Canc Inst, Bladder Canc Ctr, Dept Med, PSMAR IMIM Lab, Boston, MA 02215 USA

[5] Harvard Univ, Boston, MA 02115 USA

[6] Dana Farber Canc Inst, Dept Med Oncol, Boston, MA 02115 USA

[7] Van Andel Res Inst, Ctr Epigenet, Grand Rapids, MI 49503 USA

[8] Univ N Carolina, Lineberger Comprehens Canc Ctr, Dept Genet, Chapel Hill, NC 27514 USA

[9] Univ Texas Houston, MD Anderson Canc Ctr, Dept Bioinformat & Computat Biol, 1515 Holcombe Blvd, Houston, TX 77030 USA

[10] Univ Fed Parana, Polytech Ctr, Bioinformat & Syst Biol Lab, BR-80060000 Curitiba, Parana, Brazil

[11] NIEHS, NIH, Genome Integr & Struct Biol Lab, POB 12233, Res Triangle Pk, NC 27709 USA

[12] Mem Sloan Kettering Canc Ctr, Ctr Mol Oncol, New York, NY 10065 USA

[13] Univ Calif San Diego, Sch Med, Dept Pathol, La Jolla, CA 92093 USA

[14] Univ Texas Houston, MD Anderson Canc Ctr, Dept Pathol, 1515 Holcombe Blvd, Houston, TX 77030 USA

[15] Univ Estadual Campinas, Dept Stat, Biostat & Computat Biol Lab, BR-13083859 Sao Paulo, Brazil

[16] Univ Texas Houston, MD Anderson Canc Ctr, Dept Syst Biol, 1515 Holcombe Blvd, Houston, TX 77030 USA

[17] NIEHS, NIH, Integrat Bioinformat Support Grp, POB 12233, Res Triangle Pk, NC 27709 USA

[18] Univ Alabama Birmingham, Dept Epidemiol, Birmingham, AL 35294 USA

[19] Res Inst Nationwide Childrens Hosp, Biospecimen Core Resource, Columbus, OH 43205 USA

[20] Harvard Med Sch, Brigham & Womens Hosp, Dana Farber Canc Inst, Dept Med Oncol, 75 Francis St, Boston, MA 02115 USA

[21] Dana Farber Canc Inst, Pathol & Med Oncol, Boston, MA 02115 USA

[22] Johns Hopkins Univ, Greenberg Bladder Canc Inst, Baltimore, MD 21218 USA

[23] Harvard Med Sch, Brigham & Womens Hosp, Dept Med, Boston, MA 02115 USA

[24] Baylor Coll Med, Dan L Duncan Canc Ctr, Scott Dept Urol, Houston, TX 77030 USA

来源：

CELL | 2017年 / 171卷 / 03期

关键词：

SOMATIC ERCC2 MUTATIONS; PHASE PROTEIN ARRAY; UROTHELIAL CARCINOMA; GENETIC ALTERATIONS; LUMINAL SUBTYPES; EXPRESSION; RECEPTOR; ACCURATE; BASAL; QUANTIFICATION;

D O I：

10.1016/j.cell.2017.09.007

中图分类号：

Q5 [生物化学]; Q7 [分子生物学];

学科分类号：

071010 ; 081704 ;

摘要：

We report a comprehensive analysis of 412 muscleinvasive bladder cancers characterized by multiple TCGA analytical platforms. Fifty-eight genes were significantly mutated, and the overall mutational load was associated with APOBEC-signature mutagenesis. Clustering by mutation signature identified a high-mutation subset with 75% 5-year survival. mRNA expression clustering refined prior clustering analyses and identified a poor-survival "neuronal'' subtype in which the majority of tumors lacked small cell or neuroendocrine histology. Clustering by mRNA, long non-coding RNA ( lncRNA), and miRNA expression converged to identify subsets with differential epithelial-mesenchymal transition status, carcinoma in situ scores, histologic features, and survival. Our analyses identified 5 expression subtypes that may stratify response to different treatments.

引用

页码：540 / +

页数：42

共 50 条

[21] Therapeutic Opportunities in the Intrinsic Subtypes of Muscle-Invasive Bladder Cancer
McConkey, David J.
Choi, Woonyoung
Ochoa, Andrea
Siefker-Radtke, Arlene
Czerniak, Bogdan
Dinney, Colin P. N.
HEMATOLOGY-ONCOLOGY CLINICS OF NORTH AMERICA, 2015, 29 (02) : 377 - +
[22] Classification of Muscle-Invasive Bladder Cancer Based on Immunogenomic Profiling
Zhou, Xianghong
Qiu, Shi
Nie, Ling
Jin, Di
Jin, Kun
Zheng, Xiaonan
Yang, Lu
Wei, Qiang
FRONTIERS IN ONCOLOGY, 2020, 10
[23] Molecular Subtypes as a Basis for Stratified Use of Neoadjuvant Chemotherapy for Muscle-Invasive Bladder Cancer-A Narrative Review
Sjodahl, Gottfrid
Abrahamsson, Johan
Bernardo, Carina
Eriksson, Pontus
Hoglund, Mattias
Liedberg, Fredrik
CANCERS, 2022, 14 (07)
[24] A Review of Molecular Predictors of Response to Neoadjuvant Chemotherapy in Muscle-invasive Bladder Cancer
Degener, Stephan
Mata, Douglas A.
Youssef, Ramy
Goedde, Daniel
Tandogdu, Zafer
Roth, Stephan
von Rundstedt, Friedrich-Carl
MINI-REVIEWS IN MEDICINAL CHEMISTRY, 2018, 18 (13) : 1133 - 1142
[25] Immunohistochemical based molecular subtypes of muscle-invasive bladder cancer: association with HER2 and EGFR alterations, neoadjuvant chemotherapy response and survival
Helal, Duaa S. S.
Darwish, Sara A. A.
Awad, Radwa A. A.
Ali, Dina A. A.
El-Guindy, Dina M. M.
DIAGNOSTIC PATHOLOGY, 2023, 18 (01)
[26] FOXA1 Gene Expression for Defining Molecular Subtypes of Muscle-Invasive Bladder Cancer after Radical Cystectomy
Sikic, Danijel
Eckstein, Markus
Wirtz, Ralph M.
Jarczyk, Jonas
Worst, Thomas S.
Porubsky, Stefan
Keck, Bastian
Kunath, Frank
Weyerer, Veronika
Breyer, Johannes
Otto, Wolfgang
Rinaldetti, Sebastien
Bolenz, Christian
Hartmann, Arndt
Wullich, Bernd
Erben, Philipp
JOURNAL OF CLINICAL MEDICINE, 2020, 9 (04)
[27] Predictors of Outcome of Non-Muscle-Invasive and Muscle-Invasive Bladder Cancer
Youssef, Ramy F.
Lotan, Yair
THESCIENTIFICWORLDJOURNAL, 2011, 11 : 369 - 381
[28] Collagen stiffness promoted non-muscle-invasive bladder cancer progression to muscle-invasive bladder cancer
Zhu, Huier
Chen, Hui
Wang, Jizhong
Zhou, Ling
Liu, Shaoyan
ONCOTARGETS AND THERAPY, 2019, 12 : 3441 - 3457
[29] Triple-marker immunohistochemical assessment of muscle-invasive bladder cancer: Is there prognostic significance?
Labban, Muhieddine
Najdi, Jad
Mukherji, Deborah
Abou-Kheir, Wassim
Tabbarah, Abeer
El-Hajj, Albert
CANCER REPORTS, 2021, 4 (02)
[30] Treatment of muscle-invasive and advanced bladder cancer in 2020
Patel, Vaibhav G.
Oh, William K.
Galsky, Matthew D.
CA-A CANCER JOURNAL FOR CLINICIANS, 2020, 70 (05) : 404 - 423

← 1 2 3 4 5 →